Latest 10-K annual reports

Bioxytran, Inc. filed its annual report for the year ended December 31, 2025, detailing progress in its pharmaceutical development pipeline and financial status.

Flexible Solutions International, Inc. filed its annual report for the fiscal year ended December 31, 2025, detailing operational performance, financial metrics, and future outlook.

Nortech Systems Incorporated filed an amendment to its 2025 annual report on Form 10-K, primarily to include conformed signatures on exhibits.

FRP Holdings, Inc. reported its fiscal year 2025 results, noting a transitional year with moderated NOI growth and a decline in net income, largely due to acquisition expenses and strategic investments.

Horizon Space Acquisition I Corp. (HSPO) has filed its 2025 Form 10-K, detailing its ongoing search for a business combination and its financial status, including extensions and related party loans.

GeoVax Labs, Inc. filed its annual report for the fiscal year ended December 31, 2025, detailing progress in its vaccine development programs for mpox, smallpox, COVID-19, and cancer, alongside financial performance and ongoing funding needs.

CS Diagnostics Corp. reported a significant increase in revenue for fiscal year 2025, primarily due to an Affiliate Revenue Agreement, while facing ongoing liquidity constraints and a material weakness in internal controls.

Cloudweb, Inc. filed its 2025 10-K, reporting no revenue, a net loss of $70,427, and substantial doubt about its ability to continue as a going concern due to its accumulated deficit and working capital deficiency.

AstroNova, Inc. announced its fiscal year 2026 results, detailing a slight revenue decrease and a net loss, while also initiating a strategic review of alternatives to maximize shareholder value.

Inception Growth Acquisition Limited's Form 10-K details its ongoing efforts to complete a business combination, its delisting from Nasdaq, and multiple extensions of its deadline, currently set for May 13, 2026.

OneMeta Inc. announces significant revenue increase for fiscal year 2025, driven by new contracts and product development, while addressing ongoing operational challenges.

SHF Holdings, Inc. filed its annual report for the fiscal year ended December 31, 2025, detailing a significant revenue decline, strategic adjustments to its commercial alliance agreement, and ongoing efforts to address internal control weaknesses.

IGTA Merger Sub Limited files its 2025 Annual Report on Form 10-K, detailing its formation, ongoing business combination efforts with AgileAlgo Holdings, and financial status.

BioForce Nanosciences Holdings, Inc. files its 2025 Form 10-K, detailing its transition to nutritional supplements and ongoing financial challenges.

Greenlit Ventures Inc. filed its 2025 10-K, detailing its ongoing development in the encryption sector and its financial status, which remains dependent on future financing.

Allied Energy, Inc. (AGGI) has reported a substantial increase in revenue for the fiscal year ended December 31, 2025, driven by its AI-powered social commerce platform, BILI.

Loan Artificial Intelligence Corp. (LAAI) has filed its 2025 Form 10-K, detailing its ongoing efforts to identify and execute a business combination, with no revenue generated and continued operating losses.

Vystar Corporation filed its annual report on Form 10-K for the fiscal year ended December 31, 2025, detailing financial performance, business operations, and risk factors.

Sativus Tech Corp. files an amendment to its 2025 10-K report to correct a clerical error in the auditor's report date.

Veritone, Inc. filed its annual report detailing its common stock, corporate governance provisions, and financial condition, highlighting ongoing efforts to manage liquidity and operational efficiency.

Limitless X Holdings Inc. reported a significant net loss of $46.1 million for the fiscal year ended December 31, 2025, with substantial operating expenses and a going concern uncertainty noted by auditors.

Dynamic Aerospace Systems Corporation (DAS) filed its annual report for the fiscal year ended December 31, 2025, detailing its strategic pivot to UAV manufacturing and autonomous logistics, alongside significant asset acquisitions and ongoing capital-raising efforts.

Mosaic ImmunoEngineering's 10-K filing reveals significant going concern risks due to insufficient working capital and ongoing discussions for a potential acquisition of Oncotelic's technologies, which could lead to substantial dilution.

BioRegenx, Inc. filed its 2025 10-K, reporting a 21% decrease in net sales to $1.85 million and a significant reduction in net loss to $1.54 million, while facing ongoing going concern uncertainties.

Quantumzyme Corp. files Amendment No. 2 to its 2025 10-K to clarify intellectual property ownership related to its CEO and an enzyme for ibuprofen synthesis.

Mentor Capital, Inc. filed its annual report for the fiscal year ended December 31, 2025, detailing its strategic shift towards energy assets and its financial performance.

GivBux Inc. has entered into a Securities Purchase Agreement to issue convertible promissory notes and warrants, aiming to raise up to $10 million to fund its general working capital and operating expenses.

FOXO Technologies Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2025, detailing significant revenue growth driven by recent acquisitions, alongside ongoing efforts to manage its financial position and capital structure.

CarMax, Inc. announced the appointment of Keith Barr as President and CEO, effective March 16, 2026, alongside its fiscal year 2026 financial results which showed a decrease in net earnings.

Sativus Tech Corp. files its 2025 10-K, detailing its strategic pivot to saffron cultivation via its subsidiary Saffron Tech, while facing ongoing financial challenges and internal control weaknesses.